Regulatory & Compliance

Is IP Law Stifling Innovation and Liberty in Big Pharma?
Management & Regulatory Is IP Law Stifling Innovation and Liberty in Big Pharma?

The nexus of intellectual property rights, technological advancement, and personal liberties is a hotbed of contentious debate. Taking into account the perspectives of thinkers like Stephan Kinsella, we delve into the impacts that IP laws wield on industries such as pharma, while scrutinizing how

Is the DEA Stalling Cannabis Research through Bureaucracy?
Management & Regulatory Is the DEA Stalling Cannabis Research through Bureaucracy?

The pursuit of understanding the medical benefits of cannabis continues to evolve as researchers like those at MMJ BioPharma Cultivation Inc. face significant bureaucratic resistance, particularly from federal institutions such as the DEA. The company’s recent lawsuit highlights the extensive c

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later